Nisa Investment Advisors, LLC Cassava Sciences Inc Transaction History

Nisa Investment Advisors, LLC

$16.7 Billion
Q3 2024

A detailed history of Nisa Investment Advisors, LLC transactions in Cassava Sciences Inc stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 649 shares of SAVA stock, worth $17,464. This represents 0.0% of its overall portfolio holdings.

Number of Shares

649

Previous 632 2.69%

Holding current value

$17,464

Previous $7,000 171.43%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$9.57 - $35.08 $162 - $596	17 Added 2.69%	649 $19,000
Q2 2024 Jul 19, 2024	BUY	$12.35 - $26.11 $592 - $1,253	48 Added 8.22%	632 $7,000
Q1 2024 May 01, 2024	BUY	$18.44 - $26.41 $479 - $686	26 Added 4.66%	584 $11,000
Q4 2023 Jan 25, 2024	BUY	$12.64 - $30.11 $353 - $843	28 Added 5.28%	558 $12,000
Q3 2023 Nov 02, 2023	SELL	$16.64 - $25.32 $8,985 - $13,672	-540 Reduced 50.47%	530 $8,000
Q2 2023 Aug 11, 2023	BUY	$21.59 - $27.88 $2,374 - $3,066	110 Added 11.46%	1,070 $26,000
Q1 2023 May 02, 2023	BUY	$23.46 - $36.44 $15,788 - $24,524	673 Added 234.49%	960 $23,000
Q4 2022 Feb 02, 2023	SELL	$27.82 - $44.16 $11,128 - $17,664	-400 Reduced 58.22%	287 $8,000
Q3 2022 Nov 07, 2022	SELL	$16.33 - $51.06 $7,724 - $24,151	-473 Reduced 40.78%	687 $25,000
Q2 2022 Aug 03, 2022	BUY	$17.22 - $38.47 $15,497 - $34,623	900 Added 346.15%	1,160 $33,000
Q1 2022 Apr 29, 2022	SELL	$32.6 - $53.05 $1,304 - $2,122	-40 Reduced 13.33%	260 $10,000
Q4 2021 Feb 03, 2022	SELL	$36.77 - $90.91 $29,636 - $73,273	-806 Reduced 72.88%	300 $13,000
Q3 2021 Oct 18, 2021	BUY	$41.79 - $135.3 $250 - $811	6 Added 0.55%	1,106 $69,000
Q2 2021 Aug 06, 2021	SELL	$32.15 - $89.72 $749,095 - $2.09 Million	-23,300 Reduced 95.49%	1,100 $94,000
Q1 2021 Apr 26, 2021	BUY	$7.09 - $87.95 $168,033 - $2.08 Million	23,700 Added 3385.71%	24,400 $1.1 Million
Q4 2020 Jan 25, 2021	BUY	$6.79 - $12.25 $4,753 - $8,575	700 New	700 $5,000

Others Institutions Holding SAVA

# of Institutions

207

Shares Held

14M

Call Options Held

2.98M

Put Options Held

6.57M

View Full List

About CASSAVA SCIENCES INC

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $1.08B
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

More about SAVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Account

Nisa Investment Advisors, LLC Cassava Sciences Inc Transaction History